S100A9 and Alzheimer disease: Therefore, the S100A9 deficiency-mediated cognitive improvements, and a reduction of AD pathology in AD models could be explained by the increased neuroprotective cytokine IL-10 and decreased inflammatory cytokines IL-6 and TNF-α.